BSD Medical Corporation (BSDM)’s Investor and Analyst Conference Call Transcript

Selling, general and administrative expenses increased to about 1.9 million from 1.7 million in the first quarter of fiscal 2014. That loss was 2.0 million or about 5 cents per share of fiscal 2015. Compared to a net loss of 1.5 million or 4.4 cents per share for the first quarter of fiscal 2014. As of the end of November, we had cash and cash equivalents of 6.2 million dollars and long term debt. Before I turn the time back to Clint ,I would like to say that take this time to say that we have gotten to know Clint quite well spending a lot of time with him over the last sixty days. I can tell you that he is a dynamic yet pragmatic leader, and he has demonstrated great success in commercialization and turnaround situations in med tech companies which is precisely, what BSD medical needs at this point in its life.

Now we just finished a three day spin in San Francisco and the JP Morgan conference. The JP Morgan health care conference is a huge conference where investors, strategists and analysts and other companies come together and present their stories and talk with each other network and look for resources that can help benefit each other going forward. And, we have a lot of very good meetings, I was impressed with the number of individuals that Clint knows in this area and hold him in high regard and respect and the story that we told during these last three days was very well received, so with that I will return the time back to Clint.